Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic
Kristin Mattocks, David T. Moore, Dora Lendvai Wischik, Christina M. Lazar, Marc I. Rosen
Topics & Concepts
BuprenorphineTelemedicineHarm reductionOpioid use disorderMedicineVeterans AffairsPandemicTelehealthHealth careQualitative researchNursingHarmFamily medicineMedical emergencyPublic healthCoronavirus disease 2019 (COVID-19)PsychologyOpioidDiseaseSocial psychologyEconomicsInternal medicineReceptorSocial scienceInfectious disease (medical specialty)SociologyEconomic growthPathologyOpioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskTelemedicine and Telehealth Implementation